Droptics Performance Eye Drops Liquid
FDA Label NDC 85211-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Droptics Llc for the product Droptics Performance Eye Drops (NDC 85211-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, directions, other information, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Naphozoline Hydrochloride 0.03%
Propylene Glycol: 1.0%

Purpose

Redness Reliver
Lubricant

Uses

Temporarily relieves burning and irritation due to dryness of the eye
Relieves redness of the eye due to minor eye irritations

Warnings

For external use only
Ask a doctor before use if you have narrow angle glaucoma
When using this product
• Do not touch tip of container to any surface to avoid contamination
• Replace each cap after each use
• Do not use if solution changes color or becomes cloudy
• Overuse may cause more eye redness
• Pupils may become enlarged temporarily
• Remove contact lenses before use
Stop Use and ask a doctor if
• You feel eye pain
• Changes in vision occur
• Redness or irritation of the eyes lasts
• Condition worsens or lasts more than 72 hours
Keep out of reach of children
• If swallowed, get medical help or contact a Poison Control center right away

Directions

Put 1 or 2 drops in the affected eye(s) up to 4 times daily

  • Tightly screw on cap to seal after use

Other Information

Store at 20 - 25°C (68 -77°F)

Inactive Ingredients

benzalkonium chloride, boric acid, borneol, caffeine, camphor, menthol, potassium l-aspartate, purified water, taurine

Product Label

Image Description (Image 001)

Image Description (Image 001)

* Please review the disclaimer below.